MACKENZIE FINANCIAL CORP
Position in BCRX — Biocryst Pharmaceuticals Inc
CIK 919859
TORONTO ONTARIO, A6
Position in BCRX
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$3,472,990
+$1,155,670 QoQ
Shares Held
347,299
+42.7% QoQ
Ownership
0.136%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#77
of 316 holders
Holding Since
Sep 2021
19 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BCRX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026MACKENZIE FINANCIAL CORP holds $92,574,463 across 16 Drug Manufacturers - Specialty & Generic names. BCRX ranks #7 (3.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NBIX |
Neurocrine Biosciences Inc
|
175,685 | $29,609,949 | |
| 2 | ZTS |
Zoetis Inc.
|
268,075 | $19,263,869 | |
| 3 | IRWD |
Ironwood Pharmaceuticals Inc
|
2,367,493 | $9,967,145 | |
| 4 | VTRS |
Viatris Inc
|
572,287 | $9,087,917 | |
| 5 | UTHR |
UNITED THERAPEUTICS Corp
|
15,849 | $8,587,463 | |
| 6 | CRON |
Cronos Group Inc.
|
1,597,039 | $4,439,768 | |
| 7 | BCRX |
Biocryst Pharmaceuticals Inc
This page
|
347,299 | $3,472,990 | |
| 8 | TEVA |
Teva Pharmaceutical Industries Ltd
|
91,604 | $3,103,543 |
All Filings in BCRX
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,472,990 | 347,299 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $2,317,320 | 243,416 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $1,175,678 | 150,728 | Shares | Sole | 2026-02-18 | |
| 2025-09-30 | $981,516 | 129,317 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $954,087 | 106,483 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $871,935 | 116,258 | Shares | Sole | 2025-05-07 | |
| 2024-12-31 | $636,658 | 84,662 | Shares | Sole | 2025-05-02 | |
| 2024-09-30 | $221,365 | 29,127 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $172,502 | 27,913 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $163,865 | 32,257 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $140,399 | 23,439 | Shares | Sole | 2024-01-30 | |
| 2023-09-30 | $94,964 | 13,413 | Shares | Sole | 2023-10-25 | |
| 2023-06-30 | $366,657 | 52,082 | Shares | Sole | 2023-08-03 | |
| 2023-03-31 | $491,059 | 58,880 | Shares | Sole | 2023-04-24 | |
| 2022-12-31 | $245,212 | 21,360 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $662,596 | 52,587 | Shares | Sole | 2022-10-07 | |
| 2022-06-30 | $250,280 | 23,656 | Shares | Sole | 2022-08-10 | |
| 2022-03-31 | $289,525 | 17,806 | Shares | Sole | 2022-05-13 | |
| 2021-09-30 | $149,778 | 10,423 | Shares | Sole | 2021-11-08 | |
| No filing history on record for this holder in this stock. | ||||||